Avelumab demonstrates promise in advanced NSCLC.

ABSTRACT:

SUBMITTER: Marciscano AE 

PROVIDER: S-EPMC5732688 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature